ENDOLOGIX, INC.
|
|||
(Exact name of registrant as specified in its charter)
|
|||
|
|||
Delaware
|
000-28440
|
68-0328265
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
11 Studebaker, Irvine, CA
|
92618
|
||
(Address of principal executive offices)
|
(Zip Code)
|
||
|
|
||
Registrant’s telephone number, including area code:
(949) 595-7200
|
|||
|
|||
N/A
|
|||
(Former name or former address, if changed since last report)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Class III Nominee
|
Votes For
|
Votes Withheld
|
Broker Non-votes
|
Gregory D. Waller
|
50,116,065
|
1,893,391
|
5,008,046
|
Thomas C. Wilder, III
|
50,873,702
|
1,135,754
|
5,008,046
|
Thomas F. Zenty, III
|
51,612,665
|
396,791
|
5,008,046
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
50,619,070
|
374,354
|
41,677
|
5,008,046
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
44,132,123
|
6,864,805
|
38,173
|
5,008,046
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
50,970,607
|
58,665
|
5,829
|
5,008,046
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
55,577,394
|
464,590
|
1,163
|
5,008,046
|
Exhibit No.
|
|
Description
|
10.1
|
|
2006 Stock Incentive Plan, as amended (incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 26, 2013).
|
10.2
|
|
Amended and Restated 2006 Employee Stock Purchase Plan, as amended (incorporated by reference to Appendix B of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 26, 2013).
|
|
|
ENDOLOGIX, INC.
|
|
|
|
Date: May 24, 2013
|
|
/s/ Shelley B. Thunen
|
|
|
Shelley B. Thunen
|
|
|
Chief Financial Officer
|
Exhibit No.
|
|
Description
|
10.1
|
|
2006 Stock Incentive Plan, as amended (incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 26, 2013).
|
10.2
|
|
Amended and Restated 2006 Employee Stock Purchase Plan, as amended (incorporated by reference to Appendix B of the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 26, 2013).
|